Hindson Benjamin J.'s Form 4 filing
10x Genomics, Inc. (TXG) · filed Jan 5, 2022
- Accession no.
- 0001567619-22-000621
- Filed
- Jan 5, 2022
- Trade date
- Jan 3, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions and 2 derivative transactions. Open-market sales total $6.09M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hindson Benjamin J.CIK 0001786391 | Director, Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2022 | Class A Common Stock | MOption exerciseAcquired | +2,084 | $11.48 | +$23,924.32 | 162,770 | Direct | |
| Jan 3, 2022 | Class A Common Stock | MOption exerciseAcquired | +39,582 | $74.58 | +$2,952,025.56 | 202,352 | Direct | |
| Jan 3, 2022 | Class A Common Stock | SSaleDisposed | −2,300 | $144.56F2 | −$332,488 | 200,052 | Direct | |
| Jan 3, 2022 | Class A Common Stock | SSaleDisposed | −16,464 | $145.43F3 | −$2,394,359.52 | 183,588 | Direct | |
| Jan 3, 2022 | Class A Common Stock | SSaleDisposed | −17,396 | $146.29F4 | −$2,544,860.84 | 166,192 | Direct | |
| Jan 3, 2022 | Class A Common Stock | SSaleDisposed | −2,906 | $147.34F5 | −$428,170.04 | 163,286 | Direct | |
| Jan 3, 2022 | Class A Common Stock | SSaleDisposed | −2,000 | $148.44F6 | −$296,880 | 161,286 | Direct | |
| Jan 3, 2022 | Class A Common Stock | SSaleDisposed | −600 | $149.24F7 | −$89,544 | 160,686 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2022 | Class A Common Stock | MOption exerciseDisposed | −2,084 | $0.00 | $0 | 31,250 | Direct | |
| Jan 3, 2022 | Class A Common Stock | MOption exerciseDisposed | −39,582 | $0.00 | $0 | 93,630 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $143.89 to $144.85. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $144.89 to $145.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $145.89 to $146.8725. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $146.89 to $147.87. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $147.93 to $148.925. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $149.09 to $149.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
Remarks
Chief Scientific Officer and President